• AWS Tears Down Private Clouds

    Nov 14, 2013, 08:00 AM by Michael Croft
    Computerworld | At the Amazon Web Services Reinvent conference, Andy Jassy spared nothing in his assessment of private clouds, saying they offer "none of the benefits" of public cloud offerings.
    Full story
  • Eli and Edythe Broad Invest Another $100M in Broad Institute

    Nov 14, 2013, 07:00 AM by Michael Croft
    Bio-IT World News Brief | American philanthropists and entrepreneurs Eli and Edythe Broad are investing an additional $100 million into the Broad Institute to launch a new decade of transformative work to harness recent biomedical discoveries to benefit patients.
    Full story
  • Myriad Releases Three New Tests

    Nov 13, 2013, 12:00 PM by Michael Croft
    Bio-IT World | Myriad Genetics got their fare share of press this summer when the Supreme Court ruled that Myriad’s gene patents were invalid. But in the past three months, the company has released three diagnostic and prognostic tests. Patent or no patent, they’ve been busy.
    Full story
  • 'A Blunt and Reckless Tool'

    Nov 12, 2013, 12:15 PM by Michael Croft
    ScienceWorksForU.S. | A survey of American research universities, conducted by a trio of higher education organizations, attempts to quantify where cuts to scientific research due to the sequester are being directed.
    Full story
  • GSK Names Winners in Idea Competition

    Nov 12, 2013, 12:00 PM by Michael Croft
    Philadelphia Inquirer | GlaxoSmithKline's first "Discovery Fast Track" competition named winners last week from a pool of 134 applicants.
    Full story
  • November News Briefs

    Nov 12, 2013, 11:35 AM by Michael Croft
    Bio-IT World | News briefs from around the industry, including new life science partnerships from Thomson Reuters, personalized diabetes care software at the UNC School of Medicine and SAS, and
    Full story
  • Just How Significant is p=.05?

    Nov 12, 2013, 08:45 AM by Michael Croft
    Bio-IT World News Brief | A paper published today in The Proceedings of the National Academy of Sciences suggests that many irreproducible findings in the scientific literature may be the result of a too-lenient standard for establishing statistical significance.
    Full story
  • Illumina Names New President: Francis deSouza

    Nov 11, 2013, 20:00 PM by Michael Croft
    Bio-IT World News Brief | Illumina today announced that Francis deSouza will take on the role of President, reporting to CEO Jay Flatley. deSouza will lead Illumina's business units and the core functions responsible for envisioning, developing and producing the company’s products. He will join the team in December.
    Full story
  • Microfabrication Leveraged Toward Single-Cell Genomics

    Nov 11, 2013, 12:00 PM by Michael Croft
    Nature Biotechnology | Researchers at the Bioengineering Department of the University of California, San Diego, have made progress in bringing single-cell genome sequencing to a level of precision on par with multi-cell approaches.
    Full story
  • Drug Development Over the Past 20 Years

    Nov 11, 2013, 11:00 AM by Michael Croft
    In the Pipeline | PLOSOne has posted a new paper tracking drug development over the past 20 years looking at patents and publications. The data shows--among other things--a peak in patents in 2008, and since then a decline.
    Full story
  • Advice on Computational Biology

    Nov 11, 2013, 11:00 AM by Michael Croft
    Nature Biotechnology | Nick Loman and Mick Watson give advice on becoming a computational biologist. Among their tips: set traps for your own scripts and other people's.
    Full story
  • IBM to Beat Amazon at Cloud?

    Nov 11, 2013, 07:00 AM by Michael Croft
    Computerworld | IBM will beat Amazon Web Services, claims a Computerworld opinion piece. Amazon isn't, at heart, an IT services company.
    Full story
  • UC Santa Cruz Wins DREAM Breast Cancer Challenge

    Nov 8, 2013, 13:00 PM by Michael Croft
    Bio-IT World News Brief | A team of bioinformatics experts at UC Santa Cruz made the most accurate predictions in a competitive challenge to identify signaling networks in breast cancer cells. The results of the HPN-DREAM breast cancer network inference challenge were announced today in Toronto.
    Full story
  • DNASTAR Opens for Business in BaseSpace

    Nov 8, 2013, 12:30 PM by Michael Croft
    Bio-IT World | One year after the release of DNASTAR’s first cloud application, the desktop genome analysis company has developed cloud capabilities for its enterprise software suite, and now a commercial presence inside BaseSpace.
    Full story
  • Sometimes You Can Trust a Rat

    Nov 8, 2013, 09:45 AM by Michael Croft
    Bio-IT World News Brief | The results of the second sbv IMPROVER challenge have delivered a surprising level of validation for rodent models of genetic pathways in human cells.
    Full story
  • A Year-End Flurry of Activity at Ion Torrent

    Nov 8, 2013, 08:15 AM by Michael Croft
    Bio-IT World | November and December are shaping up to be big months for the next-generation sequencing company, as four new products to speed up and refine the sequencing workflow are scheduled for early release in the coming weeks.
    Full story
  • Crispr Cuts and Stitches

    Nov 7, 2013, 08:00 AM by Michael Croft
    Independent | Crispr, the unwieldy acronym for palindromic repeats in DNA, was thought to be junk DNA for years. Turns out, that is definitely not the case.
    Full story
  • EMC Sues Pure Storage

    Nov 6, 2013, 12:00 PM by Michael Croft
    Computerworld | EMC has sued Pure Storage for colluding with former employees to collect EMC information and trade secrets.
    Full story
  • Biodatomics' Open Source Approach

    Nov 6, 2013, 09:45 AM by Michael Croft
    Bio-IT World | A number of open source informatics tools have grown popular with genetic researchers performing specific workflows. Now, Biodatomics thinks the market is ready to scale up to an open source end-to-end genomic analysis platform.
    Full story
  • 'HaploSeq' Pins Variants to Their Chromosomes

    Nov 5, 2013, 08:00 AM by Michael Croft
    Nature Biotechnology | To RNAseq and ChIPseq, add HaploSeq: a new sequencing method that not only identifies variants in an individual's genome, but also links them together into haplotypes.
    Full story